Polymer-iodine inactivation of the human immunodeficiency virus

Journal of the American College of Surgeons

Volumn 183, Issue 3, 1996, Pages 195-200

  Shikani, Alan H ^a,d   Clair, Marty St ^b   Domb, Abraham ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Burroughs Wellcome Co   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Good Samaritan Professional Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; POLYURETHAN; TETRAHYDROFURAN;

ARTICLE; DESORPTION; DIFFUSION; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS INACTIVATION; WASTE DISPOSAL; WASTE MANAGEMENT;

DELAYED-ACTION PREPARATIONS; DISINFECTANTS; DISINFECTION; DRUG DELIVERY SYSTEMS; EQUIPMENT AND SUPPLIES; EQUIPMENT CONTAMINATION; HIV-1; IODINE; POLYMERS; POLYURETHANES;

EID: 9544229700     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Barre-Sinoussi, F., Chermann, J., Rey, F., and others. Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 1983, 220: 868-871.
2. Gallo, R., Salahuddin, S., Popovic, M., and others. Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science, 1984, 224: 500-503.
3. Barns, D. Grim projection for AIDS epidemic. Science, 1986, 232: 1589-1590.
4. HIV prevalence, projected AIDS case estimates: workshop, October 31, November 1, 1989. J. A. M. A., 1990, 263: 1477-1480.
5. Curran, D., Morgan, W., Hardy, A., and others. The epidemiology of AIDS: Current status and future prospects. Science, 1985, 229: 1352-1357.
6. Ho, D., Schooley, R., Rota, T., and others. HTLV III in the semen and blood of a healthy homosexual man. Science, 1984, 226: 451-453.
7. HIV prevalence estimates and AIDS case projections for the United States: report based on a workshop. Morb. Mortal. Wkly. Rep., 1990, 39: 1-31.
8. Garland, F., Mayers, D., Hickley, T., and others. Incidence of human immunodeficiency virus seroconversion in U.S. Navy and Marine Corps personnel, 1986 through 1988. J. A. M. A., 1989, 262: 3161-3165.
9. McNeil, J., Brundage, J., Wann, F., and others. Direct measurement of human immunodeficiency virus sero-conversion in serially tested population of young adults in the United States Army, October 1985 to October 1987. N. Engl. J. Med., 1989, 320: 1581-1585.
10. Update: acquired immunodeficiency syndrome-Europe. Morb. Mortal. Wkly. Rep., 1990, 39: 850-853.
11. Wolinsky, S., Wike, C., Korber, B., and others. Selective transmission of human immunodeficiency virus type-I varient from mothers to infants. Science, 1992, 255: 1134-1137.
12. "Critical Moment" at hand in HIV/AIDS pandemic, new global strategy to arrest its spread proposed. J. A. M. A., 1992, 268: 445-446.
13. Ho, D., Byimgton, R., Schooley, R., and others. Infrequency of isolation of HTLV III virus from saliva in AIDS. [letter]. N. Engl. J. Med., 1985, 313: 1606.
14. Fujikawa, L., Salahuddin, S., and Palestine, A. Isolation of human immunodeficiency virus type III from the tears of a patient with acquired immunodeficiency syndrome. Lancet, 1985, 2: 529-530.
15. Ho, D., Rota, T., Schooley, R., and other. Isolation of HTLV III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med., 1985, 313: 1493-1497.
16. The state of Maryland communicable diseases bulletin, December 1990: occupational exposure to human immunodeficiency virus.
17. Regnier, S. J. ACS/CDC meeting explores risks of blood-borne pathogens. Bull. Am. Coll. Surg., 1994, 79: 30-38.
18. Resnick, L., Veren, K., Salahuddin, S., and others. Stability and inactivation of HTLV III/LAV under clinical and laboratory environments. J. A. M. A., 1986, 255: 1887-1891.
19. Spire, B., Barre-Sinoussi, F., Montagnier, L., and others. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet, 1984, 2: 898-901.
20. Bond, W., Peterson, J., and Favero, M. Viral hepatitis B, aspects of environmental control. Health Lab. Sci., 1977, 14: 235-252.
21. Wainberg, M., Spiro, B., Bleau, G., and others. Inactivation of human immunodeficiency virus type I in tissue culture fluid and genital secretions by the spermicide benzalkonium chloride. J. Clin. Microbiol., 1990, 28: 156-158.
22. Martin, L. S., McDougal, J. S., and Loskoski, S. L. Disinfection and inactivation of the human T-lymphotrophic virus type III/lymphadenopathy-associated virus. J. Infect. Dis., 1985, 152: 400-403.
23. Kobayashi, H., Tsuzuki, M., Koshimizu, K., and others. Susceptibility of hepatitis B virus to disinfectants or heat. J. Clin. Microbiol., 1984, 20: 214-216.
24. Kaplan, J., Crawford, D., Durno, A., and others. Inactivation of human immunodeficiency virus by Betadine. Infect. Control, 1987, 8: 412-414.
25. Schuster, M., Cohn, J., and McMeeking, A. Disinfection for HTLV III: Halogenated Soaps. J. A. M. A., 1986, 255: 2290-2291.
26. Goldenheim, P. Inactivation of HIV by povidone-iodine. J. A. M. A., 1987, 257: 2434.
27. Rutala, W. APIC guideline for selection and use of disinfectants. Am. J. Infect. Control, 1990, 18: 99-117.
28. Harbison, M., and Hammer, S. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. J. Acquir. Immune. Defic. Syndr., 1989, 2: 16-29.
29. Klein, M., and Deforest, A. The inactivation of viruses by germicides. Chem. Specialists Manuf. Assoc. Proc., 1963, 49: 116-118.
30. Berkleman, R., Holland, B., and Anderson, R. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J. Clin. Microbiol., 1982, 15: 635-639.
31. Sattar, S., Raphael, R., Lochnan, H., and others. Rotavirus inactivation by chemical disinfectants and antiseptics used in hospitals. Can. J. Microbiol., 1983, 29: 1464-1469.
32. Trooskin, S. Z., Donetz, A. P., Harvy, R. A., and Greco, R. S. Prevention of catheter sepsis by antibiotic bonding. Surgery, 1985, 97: 547-551.
33. Trooskin, S. Z., Harvy, R. A., Donetz, A. P., and Greco, R. S. Application of antibiotic bonding to CAPD catheters. Frontiers in Peritoneal Dialysis, 1986, 157-160.
34. Bayston, R., and Miller, R. D. G. Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J. Clin. Pathol. 1981, 34: 1057-1062.
35. Averett, D. A. Anti-HIV compound assessment by two novel high capacity assays. J. Virol. Methods, 1989, 23: 263-276.
36. Schwartz, O., Henin, Y., Marechal, V., and Montagnier, L. A rapid and simple colorimetric test for the study of anti-HIV agents. AIDA Res. Hum. Retroviruses, 1988, 4: 441-448.
37. Rhodes, R. S. Hepatitis B virus, surgeons, and surgery. Bull. Am. Coll. Surg., 1995, 80: 32-42.
38. Shapiro, C. N. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg. Clin. North Am., 1995, 75: 1047-1056.
39. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public safety-workers. Morb. Mortal. Wkly. Rep., 1989, 38: 1-39.